コーパス検索結果 (1語後でソート)
通し番号をクリックするとPubMedの該当ページを表示します
1 e inhibitors) and non-pharmacotherapy (e.g., cognitive-behavior therapy).
2 894 adults with major depressive disorder to cognitive behavior therapy.
3 ered most strongly to the ideal prototype of cognitive behavior therapy.
4 ts in delusions and hallucinations following cognitive behavior therapy.
5 ome in the treatment of bulimia nervosa with cognitive behavior therapy.
6 mpared treatment outcomes for imipramine and cognitive behavior therapy.
7 p profile were relatively less responsive to cognitive behavior therapy.
8 average of 3 weeks with intensive individual cognitive behavior therapy.
9 d implementation of the skills emphasized in cognitive behavior therapy.
10 parenting skills training, play therapy, and cognitive behavior therapy.
11 mission to escitalopram and poor response to cognitive behavior therapy.
12 treatment with combination escitalopram and cognitive behavior therapy.
13 (10-20 mg/d) or 16 sessions of manual-based cognitive behavior therapy.
14 or (2) switch to a different medication plus cognitive behavior therapy.
15 another SSRI or venlafaxine, with or without cognitive behavior therapy.
16 interpersonal and social rhythm therapy, and cognitive behavior therapy.
17 ciated with poor response to medications and cognitive behavior therapy.
18 fessional that included multiple elements of cognitive behavior therapy.
19 n, and 2) guided self-help, an adaptation of cognitive behavior therapy.
20 ded in the primary analysis: 12 remitters to cognitive behavior therapy, 11 remitters to escitalopram
21 nths), motivational enhancement therapy plus cognitive behavior therapy (12 sessions over 6 months),
22 returned for a second testing session after cognitive behavior therapy; 13 comparison children parti
23 ng out combined) was significantly lower for cognitive behavior therapy (22%) than for nutritional co
25 significantly more of the patients receiving cognitive behavior therapy (44%) than nutritional counse
27 hs in a higher proportion of patients in the cognitive behavior therapy (71%) and supportive stress-m
28 third of those who completed self-management cognitive behavior therapy achieved high-end state funct
30 We sought to evaluate the effect of online cognitive behavior therapy (AF-CBT) on QoL in patients w
32 tment in striking contrast to 1 year PTTE in cognitive behavior therapy and < 1 week PTTE in serotoni
33 an augmentation strategy for exposure-based cognitive behavior therapy and (2) conducted in humans d
34 icipated in the follow-up study: 25 received cognitive behavior therapy and 28 received relaxation th
35 A total of 68% of the patients who received cognitive behavior therapy and 36% who received relaxati
37 e behavior therapy, and treatments combining cognitive behavior therapy and contingency management.
42 brain mean) was associated with remission to cognitive behavior therapy and poor response to escitalo
44 nt appears promising, as is a combination of cognitive-behavior therapy and morning bright light.
45 emitters to escitalopram, 9 nonresponders to cognitive behavior therapy, and 6 nonresponders to escit
46 e integrated with motivational interviewing, cognitive behavior therapy, and family intervention over
47 e integrated with motivational interviewing, cognitive behavior therapy, and family or caregiver inte
48 search topics were social anxiety disorder, cognitive behavior therapy, and randomized controlled tr
49 ency management, relapse prevention, general cognitive behavior therapy, and treatments combining cog
50 elf-help, a psychological treatment based on cognitive behavior therapy, appears ineffective, but tre
52 treatment for panic disorder, exposure-based cognitive behavior therapy, are reviewed, and their appl
53 believe is the first empirical evaluation of cognitive behavior therapy as a posthospitalization trea
54 This study aimed to evaluate whether blended cognitive behavior therapy (bCBT) can reduce the severit
55 cation to cognitive behavior therapy favored cognitive behavior therapy, but tests comparing the two
56 Serotonin reuptake inhibitors (SRIs) and cognitive behavior therapy by exposure and ritual preven
58 in a randomized controlled trial comparing a cognitive behavior therapy (CBT) and pharmacotherapy int
60 comparative effectiveness of sertraline and cognitive behavior therapy (CBT) for depression, quality
61 he clinical effectiveness of protocol-driven cognitive behavior therapy (CBT) for insomnia, delivered
62 and cost-effectiveness of family therapy and cognitive behavior therapy (CBT) guided self-care in ado
68 at augmentation with short-term OCD-specific cognitive behavior therapy (CBT) may provide additional
69 single-blind, randomized controlled trial of cognitive behavior therapy (CBT) versus usual care (UC)
70 iveness of fluoxetine hydrochloride therapy, cognitive behavior therapy (CBT), and their combination
71 ptoms of depression, clinicians should offer cognitive behavior therapy (CBT), behavioral activation
72 ns are shown for family therapy, followed by cognitive behavior therapy (CBT), motivational enhanceme
73 onin reuptake inhibitor (SSRI) sertraline or cognitive behavior therapy (CBT), participants completed
76 of interpersonal and social rhythm therapy, cognitive behavior therapy [CBT], or family-focused ther
78 reatment (BWL) and guided self-help based on cognitive behavior therapy (CBTgsh) have both resulted i
82 87 [87.0%] female), 50 in the grief-focused cognitive behavior therapy condition and 50 in the mindf
83 3 months of treatment, participants in both cognitive behavior therapy conditions had significant re
84 utcomes in the antidepressant medication and cognitive behavior therapy conditions of the Treatment o
86 er receive forms of psychotherapy other than cognitive behavior therapy, even though there is little
87 sizes comparing antidepressant medication to cognitive behavior therapy favored cognitive behavior th
89 (DCS) augments the effects of exposure-based cognitive behavior therapy for anxiety, obsessive-compul
90 rior to placebo in augmenting the effects of cognitive behavior therapy for anxiety, obsessive-compul
91 es patients who will and will not respond to cognitive behavior therapy for bulimia nervosa, potentia
94 This study reports on an open-label trial of cognitive behavior therapy for insomnia and disturbing d
97 offer a broad perspective on the subject of cognitive behavior therapy for schizophrenia for the Ame
100 sis of empirical evidence, to be superior to cognitive behavior therapy for the acute treatment of se
101 growing body of evidence supports the use of cognitive behavior therapy for the treatment of schizoph
103 in the motivational enhancement therapy plus cognitive behavior therapy group and -0.19% (CI, -0.53%
104 ssessment, participants in the grief-focused cognitive behavior therapy group showed greater reductio
105 oportions were employed, but patients in the cognitive behavior therapy group worked significantly mo
108 rapy (CT), often labeled as the generic term cognitive behavior therapy, has been shown to be effecti
111 on of the efficacy of any psychotherapy, and cognitive behavior therapy in particular, in posthospita
112 BDNF Val66Met genotype predicts response to cognitive behavior therapy in PTSD and is in accord with
113 e to psychotherapy, we examined responses to cognitive behavior therapy in relation to electroencepha
114 e authors therefore investigated response to cognitive behavior therapy in relation to pretreatment m
115 te outcomes of antidepressant medication and cognitive behavior therapy in the severely depressed out
119 livered motivational enhancement therapy and cognitive behavior therapy is feasible for adults with p
121 nitive therapy (often labeled generically as cognitive behavior therapy) is efficacious either alone
123 n the intent-to-treat group, self-management cognitive behavior therapy led to sharper declines in da
126 e-adjusted Hamilton scores were lower in the cognitive behavior therapy (mean [standard error], 5.5 [
127 hree randomized, controlled trials comparing cognitive behavior therapy, medication, and their combin
128 for prolonged grief disorder, grief-focused cognitive behavior therapy might be the more effective c
130 ar were randomly assigned to self-management cognitive behavior therapy (N=24) or supportive counseli
131 with recommended standard treatment (either cognitive behavior therapy [N=36] or imipramine [N=22]).
132 erapy intervention (8 weeks of manual-guided cognitive behavior therapy) (n = 90), or referral to com
134 duce anxiety during pregnancy through use of Cognitive Behavior Therapy, on birth outcomes with 796 w
135 of panic disorder than treatment with either cognitive behavior therapy or imipramine; results obtain
136 d to, or had relapsed following, a course of cognitive behavior therapy or interpersonal psychotherap
137 er and were treated for 16 weeks with either cognitive behavior therapy or interpersonal psychotherap
138 o eleven 90-minute sessions of grief-focused cognitive behavior therapy or mindfulness-based cognitiv
139 re randomly assigned to 1 year of outpatient cognitive behavior therapy or nutritional counseling.
140 andomly assigned to receive the two kinds of cognitive behavior therapy or received standard communit
142 pression (n = 139) were randomly assigned to cognitive behavior therapy or usual care for depression.
144 permit distinction of the additive effect of cognitive behavior therapy plus motivational enhancement
146 with PTSD underwent an 8-week exposure-based cognitive behavior therapy program and provided mouth sw
149 he association between sleep abnormality and cognitive behavior therapy response was not significant
151 Both the interpersonal psychotherapy and cognitive behavior therapy sessions adhered most strongl
152 anscripts of interpersonal psychotherapy and cognitive behavior therapy sessions conducted as part of
156 ly assigned to 1 of 3 treatments: individual cognitive behavior therapy, systemic behavior family the
158 cused interventions - such as trauma-focused cognitive behavior therapy (TF-CBT) and eye movement des
159 was to compare the efficacy of a manualized cognitive behavior therapy that addresses both posttraum
160 nce abuse (seeking safety) with a manualized cognitive behavior therapy that addresses only substance
161 before and after 16 weeks of treatment with cognitive behavior therapy to determine the stability or
162 or combined treatment is for the addition of cognitive behavior therapy to pharmacotherapy for patien
163 or most patients with BED, with IPT (or full cognitive behavior therapy) used for patients with low s
164 ens of brief interpersonal psychotherapy and cognitive behavior therapy using the Psychotherapy Proce
165 st-assisted, Internet-based, self-management cognitive behavior therapy versus Internet-based support
166 his study evaluated the long-term outcome of cognitive behavior therapy versus relaxation therapy for
167 icipated in a randomized controlled trial of cognitive behavior therapy versus relaxation therapy for
174 Outcomes of antidepressant medication and cognitive behavior therapy were compared within each of
175 esponse of patients with major depression to cognitive behavior therapy were complex and that future
176 lysis of variance treatment (escitalopram or cognitive behavior therapy) x outcome (remission or nonr